Ye Qiu, Ye Qiu, Hao Wen, Haoru Wang, Wenjun Sun, Guangchao Li, . . . Feng Ye. (2024). Real-world effectiveness and safety of nirmatrelvir-ritonavir (Paxlovid)-treated for COVID-19 patients with onset of more than 5 days: A retrospective cohort study. Frontiers Media S.A..
Chicago Style (17th ed.) CitationYe Qiu, et al. Real-world Effectiveness and Safety of Nirmatrelvir-ritonavir (Paxlovid)-treated for COVID-19 Patients with Onset of More than 5 days: A Retrospective Cohort Study. Frontiers Media S.A., 2024.
MLA (9th ed.) CitationYe Qiu, et al. Real-world Effectiveness and Safety of Nirmatrelvir-ritonavir (Paxlovid)-treated for COVID-19 Patients with Onset of More than 5 days: A Retrospective Cohort Study. Frontiers Media S.A., 2024.
Warning: These citations may not always be 100% accurate.